MarketPeel
Insider Trading Intelligence
MH

Mutya Harsch

VYNE
CHIEF LEGAL OFFICER AND GC · VYNE THERAPEUTICS INC. · CIK 0001727809
FILING MIX · LIFETIME38%/62%
BUYS
15
SELLS
24
TOTAL VALUE
$142.8K
COMPANIES
1
ACTIVE SINCE
Sep 2020
HOLDINGS NOW
118,434
AVG SELL PX
$1.62
TRADE KIND
SHOWING 39 / 39
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons
Forward-return performance of every backtestable P/S trade by Mutya Harsch, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+100.00%+5.10%+0.70%+4.40%+4.40%
14d1+100.00%+16.08%+4.37%+11.71%+11.71%
30d1+100.00%+74.90%+5.18%+69.72%+69.72%
60d1+100.00%+170.59%+6.32%+164.27%+164.27%
90d1+100.00%+91.77%+12.03%+79.74%+79.74%
180d1+100.00%+50.98%+13.42%+37.56%+37.56%
1y1+0.00%-18.04%+32.88%-50.91%-50.91%
2y1+0.00%-30.59%+47.54%-78.13%-78.13%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
VYNE · 118,434 shares · as of Jun 30, 2026
081,881163,763245,644327,525202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 15 buys / 24 sellsCOVERAGE · 24 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
VYNE
VYNE THERAPEUTICS INC.
SALE
CHIEF LEGAL OFFICER AND GC
3,464$0.65$2.3K118,434Jun 30, 2026Jul 2, 2026View →
VYNE
VYNE THERAPEUTICS INC.
SALE
CHIEF LEGAL OFFICER AND GC
4,007$0.60$2.4K121,898Mar 31, 2026Apr 2, 2026View →
VYNE
VYNE THERAPEUTICS INC.
SALE
CHIEF LEGAL OFFICER AND GC
3,579$0.58$2.1K125,905Dec 31, 2025Jan 5, 2026View →
VYNE
VYNE THERAPEUTICS INC.
SALE
CHIEF LEGAL OFFICER AND GC
3,581$0.34$1.2K129,484Sep 30, 2025Oct 2, 2025View →
VYNE
VYNE THERAPEUTICS INC.
SALE
CHIEF LEGAL OFFICER AND GC
3,581$1.65$5.9K133,065Jun 30, 2025Jul 1, 2025View →
VYNE
VYNE THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
1,145$0.81$927136,646Jun 2, 2025Jun 2, 2025View →
VYNE
VYNE THERAPEUTICS INC.
SALE
CHIEF LEGAL OFFICER AND GC
8,828$1.58$13.9K135,501Mar 31, 2025Apr 2, 2025View →
VYNE
VYNE THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
230,000230,000Jan 21, 2025Jan 23, 2025View →
VYNE
VYNE THERAPEUTICS INC.
SALE
CHIEF LEGAL OFFICER AND GC
4,697$3.35$15.7K144,329Dec 31, 2024Jan 2, 2025View →
VYNE
VYNE THERAPEUTICS INC.
SALE
CHIEF LEGAL OFFICER AND GC
105$1.88$197149,026Sep 30, 2024Oct 2, 2024View →
VYNE
VYNE THERAPEUTICS INC.
SALE
CHIEF LEGAL OFFICER AND GC
143$1.92$275149,131Jul 1, 2024Jul 3, 2024View →
VYNE
VYNE THERAPEUTICS INC.
SALE
CHIEF LEGAL OFFICER AND GC
161$3.08$496149,274Apr 1, 2024Apr 3, 2024View →
VYNE
VYNE THERAPEUTICS INC.
SALE
Chief Legal Officer and GC
161$2.28$367149,435Jan 2, 2024Jan 3, 2024View →
VYNE
VYNE THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
62,500149,596Jan 1, 2024Jan 3, 2024View →
VYNE
VYNE THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
62,50062,500Jan 1, 2024Jan 3, 2024View →
VYNE
VYNE THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
62,50087,096Dec 13, 2023Dec 15, 2023View →
VYNE
VYNE THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
62,50062,500Dec 13, 2023Dec 15, 2023View →
VYNE
VYNE THERAPEUTICS INC.
SALE
Chief Legal Officer and GC
1,154$3.83$4.4K24,596Oct 2, 2023Oct 4, 2023View →
VYNE
VYNE THERAPEUTICS INC.
SALE
Chief Legal Officer and GC
157$4.10$64425,750Jun 30, 2023Jul 5, 2023View →
VYNE
VYNE THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
3,664$3.46$12.7K25,907May 31, 2023Jun 2, 2023View →
VYNE
VYNE THERAPEUTICS INC.
SALE
Chief Legal Officer and GC
478$3.08$1.5K22,243Mar 31, 2023Apr 4, 2023View →
VYNE
VYNE THERAPEUTICS INC.
PURCHASE
Chief Legal Officer and GC
10,000$2.50$25.0K22,721Mar 20, 2023Mar 22, 2023View →
VYNE
VYNE THERAPEUTICS INC.
SALE
Chief Legal Officer and GC
1,813$0.15$272229,144Dec 31, 2022Jan 4, 2023View →
VYNE
VYNE THERAPEUTICS INC.
SALE
Chief Legal Officer and GC
1,813$0.22$404230,957Sep 30, 2022Oct 4, 2022View →
VYNE
VYNE THERAPEUTICS INC.
SALE
Chief Legal Officer and GC
1,813$0.39$705232,770Jun 30, 2022Jul 5, 2022View →
VYNE
VYNE THERAPEUTICS INC.
SALE
Chief Legal Officer and GC
3,630$0.65$2.4K234,583Mar 31, 2022Apr 4, 2022View →
VYNE
VYNE THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
75,000238,213Mar 17, 2022Mar 18, 2022View →
VYNE
VYNE THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
75,00075,000Mar 17, 2022Mar 18, 2022View →
VYNE
VYNE THERAPEUTICS INC.
SALE
Chief Legal Officer and GC
1,484$1.02$1.5K163,213Dec 31, 2021Jan 4, 2022View →
VYNE
VYNE THERAPEUTICS INC.
SALE
Chief Legal Officer and GC
1,484$1.39$2.1K164,697Sep 30, 2021Oct 1, 2021View →
VYNE
VYNE THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
60,86060,860Sep 2, 2021Sep 3, 2021View →
VYNE
VYNE THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
60,859166,181Sep 2, 2021Sep 3, 2021View →
VYNE
VYNE THERAPEUTICS INC.
SALE
Chief Legal Officer and GC
3,551$3.51$12.5K105,322Jun 30, 2021Jul 2, 2021View →
VYNE
VYNE THERAPEUTICS INC.
SALE
Chief Legal Officer and GC
1,765$6.84$12.1K108,873Mar 31, 2021Apr 2, 2021View →
VYNE
VYNE THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
68,16268,162Feb 22, 2021Feb 24, 2021View →
VYNE
VYNE THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
29,213110,638Feb 22, 2021Feb 24, 2021View →
VYNE
VYNE THERAPEUTICS INC.
SALE
Chief Legal Officer and GC
1,822$1.58$2.9K325,703Dec 31, 2020Jan 5, 2021View →
VYNE
VYNE THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
10,460$1.45$15.1K327,525Nov 30, 2020Dec 2, 2020View →
VYNE
VYNE THERAPEUTICS INC.
SALE
Chief Legal Officer and GC
1,822$1.66$3.0K317,065Sep 30, 2020Oct 2, 2020View →
Other insiders · VYNE
Loading peer insiders…
About this filer
CIK 0001727809
ROLE
CHIEF LEGAL OFFICER AND GC
PRIMARY
VYNE
COMPANIES
1
ACTIVE SINCE
Sep 2020
MARKETPEEL · /INSIDER/0001727809DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback